Amedisys board OK’s $75M stock buyback plan

    The board of directors for Baton Rouge-based home health and hospice firm Amedisys has approved a stock buyback plan, by which the company can opt to repurchase up to $75 million of its outstanding co…

    Already an INSIDER? Sign in.

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.